Medical News
Contact Us
Mechanism of umbilical cord mesenchymal stem cells in the expansion of umbilical cord blood-derived hematopoietic stem cells in vitro
07/08/2025
Journal of International Medical Research, 24/06/2025 Introduction Umbilical cord blood is one of the most promising sources of hematopoietic stem cells (HSCs), especially important in
Umbilical Cord-Derived Mesenchymal Stem Cell Therapy: A Promising Comprehensive Approach for Type 2 Diabetes Mellitus
04/08/2025
Dovepress, May 19 2025 A large-scale retrospective clinical study recently published in Diabetes, Metabolic Syndrome and Obesity has demonstrated the safety and therapeutic efficacy of
New stem cell therapy to treat patients with blood cancers
24/07/2025
EMA, 20 June 2025 Zemcelpro provides an option for patients with blood cancer who need a blood stem cell transplant and have no suitable donor
The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19
21/07/2025
Frontiers in Immunology, 17/06/2025 A new original study published in Frontiers in Immunology (Volume 16, 2025) reports preliminary findings on the safety and efficacy of
Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol
17/07/2025
BMJ,05/06/2025 A pioneering clinical trial – the ALLO Trial – is currently being conducted at Monash Children’s Hospital to evaluate the safety and feasibility of
Cord Blood Banking Starts to Live Up to its Promise
14/07/2025
Parent’s Guide to Cord Blood, June 2025 Back Story of Cell Therapy for Pediatric Neurodevelopment Disorders Since 2005, cells from cord blood or umbilical cord
Australia Allows Umbilical Cord Blood Therapy for Cerebral Palsy
10/07/2025
Parent’s Guide to Cord Blood, June 2025 Zara was the first child in Australia to receive cord blood therapy for cerebral palsy outside of a
New stem cell therapy to treat patients with blood cancers
07/07/2025
EMA, 20 June 2025 Zemcelpro provides an option for patients with blood cancer who need a blood stem cell transplant and have no suitable donor
Optimized Gmp-Grade Wharton’s Jelly’s Mesenchymal Stromal Cells Manufacturing and Administration Protocol for Graft Versus Host Disease Prevention
26/06/2025
SSRN, 20 May 2025 Mesenchymal stromal cells derived from Wharton’s jelly (WJ-MSCs) are multipotent cells originating from the umbilical cord, possessing strong immunomodulatory properties. These
Pooling umbilical cord-mesenchymal stromal cells derived from selected multiple donors reduces donor-dependent variability and improves their immunomodulatory properties
23/06/2025
Stem Cell Research & Therapy, 20/05/2025 A groundbreaking study published by Miryam Mebarki and colleagues in the journal Stem Cell Research & Therapy has demonstrated
